advvegf-d
Biologicalexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2017 (NCT03039751)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Vascular endothelial growth factor CSupplementation
VEGFC supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- advvegf-d
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03039751 | Phase 2 | Jan 1, 2017 | Euram Limited, FinVector Vision Therapies Oy, Kuopio University Hospital, Medical University of Vienna, University of Copenhagen, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Euram Limited | For profit | 1 | 0 | 1 | 2017 |
| FinVector Vision Therapies Oy | For profit | 1 | 0 | 1 | 2017 |
| Kuopio University Hospital | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Medical University of Vienna | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2017 |
6 organizations
Page 1 / 1